Your browser doesn't support javascript.
loading
Association of Coexisting Conditions, Attention-Deficit/Hyperactivity Disorder Medication Choice, and Likelihood of Improvement in Preschool-Age Children: A Developmental Behavioral Pediatrics Research Network Study.
Deavenport-Saman, Alexis; Vanderbilt, Douglas L; Harstad, Elizabeth; Shults, Justine; Barbaresi, William; Bax, Ami; Cacia, Jaclyn; Friedman, Sandra; LaRosa, Angela; Loe, Irene; Mittal, Shruti; Blum, Nathan.
Afiliación
  • Deavenport-Saman A; Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Vanderbilt DL; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Harstad E; Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Shults J; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Barbaresi W; Boston Children's Hospital, Boston, Massachusetts, USA.
  • Bax A; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Cacia J; Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Friedman S; Boston Children's Hospital, Boston, Massachusetts, USA.
  • LaRosa A; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Loe I; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Mittal S; Children's Hospital Colorado, Aurora, Colorado, USA.
  • Blum N; Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
J Child Adolesc Psychopharmacol ; 32(6): 328-336, 2022 08.
Article en En | MEDLINE | ID: mdl-35787014
ABSTRACT

Objectives:

To determine whether conditions coexisting with attention-deficit/hyperactivity disorder (ADHD) in preschool-age children are associated with choice of stimulants or alpha-2 adrenergic agonists (A2As) and/or likelihood of improvement in ADHD symptoms.

Methods:

A retrospective electronic health record review of 497 children from 7 Developmental Behavioral Pediatrics Research Network (DBPNet) sites. Children were <72 months when treated with medication for ADHD from January 1, 2013 to July 1, 2017. We abstracted coexisting conditions, initial medication prescribed, and whether the medication was associated with improvement in symptoms. Analysis of improvement was adjusted for clustering by clinician and site.

Results:

The median (interquartile range) child age at the time of initiation of ADHD medication was 62 (54-67) months. The most common coexisting conditions included language disorders (40%), sleep disorders (28%), disruptive behavior disorders (22.7%), autism spectrum disorder (ASD; 21.8%), and motor disorders (19.9%). No coexisting conditions were present in 17.1%; 1 in 36.8%, 2 in 26.8%, and ≥3 in 19.3%. Stimulants were initially prescribed for 322 (64.8%) and A2A for 175 (35.2%) children. Children prescribed stimulants were more likely to have no coexisting conditions than those prescribed A2A (22.3% vs. 7.4%; p < 0.001). Coexisting ASD and sleep disorder were associated with increased likelihood of starting A2As versus stimulants (p < 0.0005; p = 0.002). The association between medication treatment and improvement varied by number of coexisting conditions for 0, 1, 2, or ≥3, respectively (84.7%, 73.8%, 72.9%, 64.6%; p = 0.031). Children with ≥3 coexisting conditions were less likely to respond to stimulants than children with no coexisting conditions (67.4% vs. 79.9%; p = 0.037).

Conclusions:

Among preschool-age children with ADHD, those with ≥3 coexisting conditions were less likely to respond to stimulants than those with no coexisting conditions. This was not found for A2A, but further research is needed as very few children with no coexisting conditions were treated with A2A.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Trastornos del Sueño-Vigilia / Trastorno del Espectro Autista / Estimulantes del Sistema Nervioso Central Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Child / Child, preschool / Humans Idioma: En Revista: J Child Adolesc Psychopharmacol Asunto de la revista: PEDIATRIA / PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Trastornos del Sueño-Vigilia / Trastorno del Espectro Autista / Estimulantes del Sistema Nervioso Central Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Child / Child, preschool / Humans Idioma: En Revista: J Child Adolesc Psychopharmacol Asunto de la revista: PEDIATRIA / PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos